Conferences and Meetings
2025 Eos Connection: APFED’s annual patient education conference on eosinophil-associated disease
Register for free on-demand access to the recordings and the virtual environment at apfed.org/conference.
Online CME Programs
APFED partners with leading medical education providers to offer high-quality CME programs focused on eosinophil-associated diseases. These activities support clinicians in staying current on emerging research, guidelines, and best practices for patient care.
EoE Care Transitions: Shared Decision-making Across the Lifespan
Up to 1.0 AMA PRA Category 1 Credit™
Release and Expiration Dates: Sept 17, 2025 – Sept. 17, 2026
Time to Complete: 60 minutes
Designed for healthcare providers who treat young children, adolescents, or adults, this session offered by Medlive provides practical strategies to support continuity of care and improve patient outcomes.
-
Strengthen the transition from pediatric to adult care through shared decision-making
-
Update and align treatment approaches with the 2025 ACG guidelines
-
Explore data-driven insights on long-term therapies, including topical steroids
Overcoming Challenges in the Management of Severe Asthma
Expert Insights on Emerging Strategies to Close the Gaps to Optimal Care
1.0 CME/MOC/AAPA/IPCE
Release and Expiration Dates: March 28, 2025 – March 27, 2026
Time to Complete: 60 minutes
Despite significant advances in severe asthma treatments, many patients continue to experience frequent exacerbations, reduced lung function, and compromised quality of life. This comprehensive, video-based CME activity through PeerView Institute explores how clinicians can leverage the latest innovations in biologic therapies to transform patient care.
Patient Perspectives on Type 2 Inflammatory Diseases
A Holistic Approach to Comorbidity Recognition and Management
0.5 AMA PRA Category 1 Credit™
Release and Expiration Dates: March 31, 2025 – March 30, 2026
Time to Complete: 30 minutes
In this activity, experts in pediatric primary care, health policy, and patient advocacy discuss type 2 inflammation and how to manage it in primary care.